Publication | Open Access

Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer

Bone Turnover MarkersSclerostinBreast OncologyAromatase InhibitionMedicineGynecologyPathologyBreast CancerAromataseEndocrinologyOncologyRadiation OncologyOsteoporosisOsteocalcinCancer ResearchEndocrine-related Cancer